glp-1 and thyroid cancer Overscreening of patients on glucagon-like peptide-1 receptor agonists: A second “epidemic” of overdiagnosis? GLP-1RA and thyroid cancer: New

2026;16(1):e70070

Health impact: Transforming treatment for obesity, diabetes, and heart disease

Latin America held a 3% share of the market in 2025 and is expected to grow at a significant CAGR of 14% during the projection period, driven by GLP-1 medications that are driving structural health and economic shifts across Latin America by curbing surging obesity and type-2 diabetes rates, spurring vast biopharma investments, and fundamentally changing consumer habits in the fast-moving consumer goods sector

In addition, Glp1r / mice [10] were used (sex- and age-matched wild-type littermates were used as controls)

Directions for Use: Administer by intramuscular, subcutaneous or intravenous injection, 2 to 4 g per kg of body weight